Table 7.
Citral/EO Citral Rich/Constituent | Concentration | Animal/Cell Line Tested | Results | Ref. |
---|---|---|---|---|
Citral | 5–100 μg/well | Peritoneal macrophage of male BALB/c mice | 50 and 100 μg of citral significantly inhibited IL-1β and IL-10 release and LPS activation. IL-6 production by macrophages significantly decreased at citral concentrations of 5, 10, 25, 50, and 100 μg/well). |
[99] |
Citral | 0.36, 0.15, and 0.06 g/kg |
MRSA-infected mice | Citral significantly reduced the levels of TNF-α, IL-6, IL-1β, malondialdehyde, and hydroxyl radicals. Increased superoxide dismutase and glutathione enzyme levels. Reduced the lung inflammatory infiltrates infected by MRSA. |
[100] |
Citral | 300 mg/kg | Diabetes-induced rats | Gene expression of IL-6 and TNF-α in the liver were significantly downregulated. | [101] |
Citral | 50–300 mg/kg | Paw edema-induced mice | Reversed paw edema formation in mice induced by LPS and zymosan, inducers of TLR4 and TLR2 signaling. | [42] |
Citral | 300 mg/kg | Eutrophic and obese mice | Citral reduced TNF-α and serum leptin concentration after the LPS challenge. IL6 levels in the hypothalamus of obese mice were reduced. |
[102] |
Citral | 125, 250, and 500 mg/kg | Male Swiss mice | Citral reduced NO production and inhibited neutrophil migration in liver. | [103] |
Citral | 10, 20, and 40 mg/kg 3, 6, and 12 µg/mL |
Mice with LPS-induced acute lung injury Alveolar macrophages |
On in vivo LPS-induced acute lung injury, citral reduced TNF-α, IL-6, and IL-1β production. In vitro, citral inhibited the production of TNF-α, IL-6, and IL-1β in alveolar macrophages. The mechanism was associated with PPAR-γ activation. |
[104] |
Citral, neral, and geranial | 66 µM | Murine J774A.1 macrophages | Citral inhibited TNF-α and IL-6. Pure neral inhibited TNF-α secretion by 60–80%, whereas geranial 57–75%. Both neral and geranial reduced IL-6 secretion of LPS-stimulated macrophages and the expression of inflammatory mediators IL-1β, iNOS, COX-2, and NLRP-3. |
[105] |
Citral-rich fractions of Citrus lemon EO | 0.005, 0.01, and 0.02% | Murine macrophage RAW264.7 cell line | Reduced the expression of the pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 in LPS-induced macrophages. | [106] |
Cymbopogon citratus EO | 0.1% | Pre-inflamed human dermal fibroblasts | Significantly inhibited the production of the inflammatory biomarkers: vascular cell adhesion molecule 1 (VCAM-1), interferon gamma-induced protein 10 (IP-10), interferon-inducible T-cell alpha chemoattractant (I-TAC), and monokine induced by gamma interferon (MIG). | [107] |
Myrcia ovata EO | 200 and 300 mg/kg | Male Swiss mice with induced acute inflammation | Reduced leukocyte extravasation and inhibited TNF-α production by 50% and 69% at both concentrations, as well as IL-1β production by 47%. | [108] |